A case control study:The role of leukotriene receptor antagonist in cardiovascular risk
Conclusions: The results do not show a reduction of the MI risk in patients using a LTRA; situation somehow different in IS patients from primary health care centers with a slightly protective effect of montelukast in reducing the IS risk, that, however, did not reach statistical significance. Future studies should require a larger sample size and monitor asthmatic patients from primary care.
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Hoxha, M., Malaj, V., Rovati, G., Messler, M. V., Doce, C. R., Cavanillas, A. B. Tags: Airway Pharmacology and Treatment Source Type: research
More News: Asthma | Cardiology | Cardiovascular | Drugs & Pharmacology | Health Management | Heart | Heart Attack | Ischemic Stroke | Primary Care | Respiratory Medicine | Statistics | Stroke | Study